Arcutis Biotherapeutics (ARQT) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 91.6%
EBITDA Margin: 12.7%
Op. Margin: 12.7%
Net Margin: 11.6%

Op. margin of 12.7% is up 30.6% YoY — cost efficiency is improving. Net margin at 11.6% and gross margin of 91.6% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit